Chronic myeloid leukemia (CML), a myeloproliferative neoplasm, is characterized by the BCR‐ABL1 fusion gene, which results in constitutive tyrosine kinase activity. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.